SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Photoacoustic spectral analysis for gaining knowledge of the tumor microenvironment.

2.

Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer

3.

New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy

4.

Researchers investigate risk of developing multiple primary cancers after surviving bowel cancer

5.

An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot